WebJun 22, 2024 · Pathological cardiac hypertrophy is a process caused by compensatory response to long-standing biomechanical pressure or volume overload, which is commonly observed in patients with hypertension, myocardial infarction and valvular diseases. WebApr 4, 2024 · in TAC-hearts and on contractility in ET-1 treated cardiomyocytes. Therefore, we ana-lyzed whether (a) hypertrophy-reduced cardiac function in TAC-hearts can be improved by RAPA-induced autophagy, (b) ET-1-mimicked hypertrophy can decrease cardiomy-ocyte contractility by reducing autophagy, and (c) whether autophagy can …
Transverse Aortic Constriction (TAC): Why, how and …
WebApr 11, 2024 · We studied the function of PINK1 in mitophagy in isoproterenol (Iso)-induced cardiomyocyte injury and transverse aortic constriction (TAC)-induced myocardial hypertrophy. Adenovirus vectors were used to induce PINK1/Mfn2 protein overexpression. WebMar 31, 2024 · In addition, deficiency of perilipin 5 (PLIN5), a lipid droplet-associated protein that maintains the balance between lipolysis and lipogenesis, was found to irritate TAC … hollolassa myytävät asunnot
DNA Damage Response Mediates Pressure Overload–Induced
WebFeb 16, 2024 · Pressure overload left ventricular hypertrophy is a known precursor of heart failure with ominous prognosis. The development of experimental models that reproduce this phenomenon is instrumental... WebApr 10, 2024 · Transverse aortic constriction (TAC) is a well-established model of pressure overload-induced cardiac hypertrophy and failure in mice. The degree of constriction … WebApr 10, 2024 · Heart failure, ischemic heart disease, arrhythmias, cardiomyopathies, stroke, atherosclerosis and hypertension, are all common forms of CV disease. Because of the prevalence and adverse... hollola sosiaalitoimi